Generic Sweden AB (GENI) AI Stock Analysis

Top Page

Generic Sweden AB

(Nasdaq OMX AB:GENI)

Select Model

Rating:83Outperform

Price Target:SEK 42.00▲(13.21% Upside)

Action:reiterated

Date:08/21/26

The score is driven primarily by strong financial performance (profitability, debt-free balance sheet, and solid free-cash-flow conversion). Valuation is supportive with a moderate P/E and a strong dividend yield, while technicals are positive but not decisively strong enough to push the score higher.

Positive Factors

Strong ProfitabilityStrong operating and net margins indicate that the company converts revenue into earnings efficiently. Sustained profitability provides internal funding for investment, supports resilience through normal business fluctuations, and gives management greater flexibility in allocating capital over the next several quarters.

Negative Factors

Gross Margin PressureThe decline in gross margin suggests that a smaller share of revenue is currently retained after direct costs. Even with solid operating profitability, persistent pressure at this level could limit future earnings expansion and make growth less valuable if costs continue to rise faster than revenue.

Generic Sweden AB (GENI) vs. iShares MSCI Sweden ETF (EWD)

Market Cap: SEK 456.03M
Dividend Yield: 4.72%
Average Volume (3M): 14.15K
Price to Earnings (P/E): 14.4
Beta (1Y): 0.44
Revenue Growth: 6.76%
EPS Growth: 1.88%
Country: Sweden
Employees: 21
Sector: General
Sector Strength: 55
Industry: Software - Application

Generic Sweden AB Business Overview & Revenue Model

Company Description

Operating as a technology firm, Generic Sweden AB delivers messaging functionalities compatible with any application. The company additionally furnishes a comprehensive platform dedicated to digital communication services. Established in 1993, its co...

Generic Sweden AB Financial Statement Overview

Summary

Strong overall fundamentals: solid profitability (TTM operating margin ~20.7%, net margin ~16.5%), very conservative capital structure with zero debt, and healthy cash conversion (TTM operating cash flow slightly above net income; free cash flow ~93% of net income). Key offsets are some gross margin compression versus earlier years and a recent decline in equity/assets that is worth monitoring.

Income Statement

86Very Positive

Balance Sheet

92Very Positive

Cash Flow

84Very Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	192.18M	183.71M	176.45M	142.59M	127.73M	114.23M
Gross Profit	49.36M	38.81M	44.72M	38.27M	35.54M	31.93M
EBITDA	40.19M	39.58M	35.52M	30.16M	26.88M	24.25M
Net Income	31.79M	31.04M	27.25M	23.31M	20.45M	18.13M
Balance Sheet
Total Assets	97.14M	105.14M	88.97M	77.42M	68.04M	59.42M
Cash, Cash Equivalents and Short-Term Investments	45.78M	58.24M	40.62M	37.20M	32.60M	31.07M
Total Debt	0	0	0	0	0	0
Total Liabilities	36.39M	38.55M	33.75M	31.01M	29.57M	29.11M
Stockholders Equity	60.74M	66.59M	55.22M	46.41M	38.47M	30.31M
Cash Flow
Free Cash Flow	31.12M	38.98M	21.85M	19.97M	13.82M	18.44M
Operating Cash Flow	32.79M	39.73M	24.06M	21.84M	16.85M	19.89M
Investing Cash Flow	12.33M	-2.44M	9.79M	-13.87M	-3.03M	-1.45M
Financing Cash Flow	-21.51M	-19.67M	-18.44M	-15.37M	-12.29M	-9.83M

Generic Sweden AB Technical Analysis

Technical Analysis SentimentNegative

Last Price37.10

Price Trends

50DMA38.74Negative

100DMA38.67Negative

200DMA38.27Negative

Market Momentum

MACD-0.67Positive

RSI41.78Neutral

STOCH38.57Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GENI, the sentiment is Negative. The current price of 37.10 is below the 20-day moving average (MA) of 37.65, below the 50-day MA of 38.74, and below the 200-day MA of 38.27, indicating a bearish trend. The MACD of -0.67 indicates Positive momentum. The RSI at 41.78 is Neutral, neither overbought nor oversold. The STOCH value of 38.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:GENI.

Generic Sweden AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

SE:GENI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:GENI	83Outperform	SEK 456.03M	14.38	―	4.72%	6.76%	1.88%
SE:UPSALE	82Outperform	SEK 463.06M	16.98	―	7.91%	11.34%	40.60%
SE:LIME	79Outperform	SEK 3.62B	29.42	32.20%	1.57%	8.57%	17.98%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SE:ONEF	55Neutral	SEK 487.40M	-24.57	―	―	21.86%	74.32%

* General Sector Average

Performance Comparison

SE:GENI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SE:GENI	Generic Sweden AB	37.10	-7.96	-17.66%
SE:DONE	24Sevenoffice Scandinavia Ab	5.85	-0.87	-12.95%
SE:LIME	Lime Technologies AB	271.00	-90.35	-25.00%
SE:UPSALE	Upsales Technology AB	27.50	-4.59	-14.29%
SE:ONEF	Oneflow AB	17.20	-9.40	-35.34%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 21, 2026

Generic Sweden AB AI Stock Analysis

Top Page